NCT00361881View on ClinicalTrials.gov

Efficacy and Safety Study of ME-609 and Acyclovir for Treatment of Herpes Simplex Labialis

PHASE3CompletedINTERVENTIONAL
Enrollment

1,443

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

August 31, 2007

Study Completion Date

December 31, 2007

Conditions
Herpes Labialis
Interventions
DRUG

ME-609

Cream, dose 5 times daily during 5 days.

DRUG

acyclovir in ME-609 vehicle

Dose 5 times daily for 5 days

DRUG

Vehicle

Dose 5 times daily for 5 days

Trial Locations (1)

29464

Coastal Caroline Research Center, Mt. Pleasant

Sponsors

Lead Sponsor

Medivir
All Listed Sponsors
lead

Medivir

INDUSTRY

NCT00361881 - Efficacy and Safety Study of ME-609 and Acyclovir for Treatment of Herpes Simplex Labialis | Biotech Hunter | Biotech Hunter